4//SEC Filing
Olson Kenneth Fletcher 4
Accession 0001209191-20-036763
CIK 0001123494other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 6:53 PM ET
Size
9.8 KB
Accession
0001209191-20-036763
Insider Transaction Report
Form 4
Olson Kenneth Fletcher
Vice President
Transactions
- Award
Stock option (right to buy)
2020-06-11+79,235→ 79,235 totalExercise: $2.63Exp: 2027-06-11→ Common Stock (79,235 underlying) - Award
Common Stock
2020-06-11+36,756→ 53,705 total - Award
Common Stock
2020-06-11+36,756→ 90,461 total
Footnotes (5)
- [F1]Represents an award of 36,756 restricted stock units that will vest in four equal installments on December 31, 2020, 2021, 2022 and 2023.
- [F2]Includes (a) the award described in footnote (1) above, and (b) 16,949 restricted stock units with performance based vesting conditions tied to relative total shareholder return.
- [F3]Represents an award of 36,756 restricted stock units with performance based vesting conditions. These restricted stock units will vest in equal installments on June 11, 2021, 2022 and 2023, and are linked to the achievement of a relative total shareholder return of the Issuer's common stock from June 11, 2020 to the earlier of (i) June 11, 2021 or (ii) upon a change of control (measured relative to the NASDAQ Biotechnology index and based on the 20-day trading average price before each such date). The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported.
- [F4]Includes (a) the shares and awards described in footnote (2) above, and (b) the award described in footnote (3) above.
- [F5]The options vest in four equal installments on December 31, 2020, 2021, 2022 and 2023.
Documents
Issuer
HARVARD BIOSCIENCE INC
CIK 0001123494
Entity typeother
Related Parties
1- filerCIK 0001793360
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 6:53 PM ET
- Size
- 9.8 KB